Supernus Announces Release of New Clinical Data on Trokendi XR

barbara.lempert Supernus Announces Release of Exciting New Clinical Data on Trokendi XR(TM) ROCKVILLE, Md., Nov. 6, 2013 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), ...

Selvita Announces Changes to Management Board

barbara.lempert Krakow, Poland, November 5, 2013 / B3C newswire / – Polish biotechnology company Selvita, announced today the appointment of Dr. Mirosława Zydron to the position ...

Bioniche Life Sciences Inc. Announces the Appointment of a New Chief Executive Officer

barbara.lempert BELLEVILLE, ON, Nov. 4, 2013 /CNW/ – Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, ...

ThermoGenesis Announces Strategic Reorganization Initiative

barbara.lempert Company to Focus on Expanding Its AXP AutoXpress Platform Functionality for Cord Blood and Cell Therapy Applications RANCHO CORDOVA, Calif., Oct. 30, 2013 (GLOBE NEWSWIRE) ...

Neovasc Inc. Announces Publication of Positive Tiara Preclinical Data in the Journal JACC: Cardiovascular Interventions

barbara.lempert -Preclinical Studies Show Innovative Transcatheter Product to Treat Mitral Regurgitation is Safe, Technically Feasible and Results in a Well-Functioning Mitral Bioprosthesis- ...

Karo Bio Announces 2013 Interim Report

mia.burns INTERIM REPORT JANUARY-SEPTEMBER 2013 The January–September period and the third quarter 2013 in brief Net sales amounted to MSEK 37.4 (24.6), whereof the third quarter ...

Valeant Pharmaceuticals Announces Award in Anacor Dispute

mia.burns LAVAL, Quebec, Oct. 18, 2013 /CNW/ – Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today the interim final award in its previously ...

Chelsea Therapeutics Announces FDA Advisory Committee to Review Northera

barbara.lempert Chelsea Therapeutics Announces FDA Advisory Committee to Review Northera (droxidopa)           Panel Date Tentatively Set for January 14, 2014 CHARLOTTE, ...

Keryx Biopharmaceuticals Announces FDA Acceptance for Filing of Zerenex New Drug Application

barbara.lempert NEW YORK, Oct. 8, 2013 (GLOBE NEWSWIRE) — Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that its New Drug Application (NDA) for Zerenex(TM) (ferric ...

Grifols Announces Launch of the SPIRIT Registry at the NHF Annual Meeting

mia.burns RESEARCH TRIANGLE PARK, N.C., Oct. 4, 2013 /CNW/ – Grifols Inc., a leading manufacturer of life-saving plasma protein therapies, today announced the launch of the SPIRIT ...

StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants

mia.burns NEWARK, Calif., Oct. 1, 2013 (GLOBE NEWSWIRE) — StemCells, Inc.(Nasdaq:STEM) today announced that it intends to offer and sell common stock and warrants, subject to ...

Amarin Announces Enrollment of the REDUCE-IT Cardiovascular Outcomes Study Surpasses 6,000 Patients

barbara.lempert    Study Evaluating the Effectiveness of Vascepa(R) in Reducing    Major Cardiovascular Events in a High-Risk Patient Population BEDMINSTER, N.J., and DUBLIN, ...
Page 1 of 1212345...10...Last »
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS